Skip to main content
Download PDF

Effects of anesthetic depth on perioperative T lymphocyte subsets in patients undergoing laparoscopic colorectal cancer surgery: a prospective, parallel-controlled randomized trial

BMC Anesthesiology volume 23, Article number: 165 (2023) Cite this article

Abstract

Background

During the perioperative period, the surgical stress response induced by surgical trauma tends to cause a decrease in peripheral lymphocytes. Anesthetics could reduce the stress response during surgery and prevent sympathetic nerve overexcitation. The goal of this study was to investigate how BIS-guided anesthetic depth affected peripheral T lymphocytes in patients undergoing laparoscopic colorectal cancer surgery.

Methods

A total of 60 patients having elective laparoscopic colorectal cancer surgery were randomly assigned and analyzed (n = 30 for deep general anesthesia, BIS 35, n = 30 for light general anesthesia, BIS 55). Blood samples were collected immediately before anesthesia induction and immediately after operation, 24 h and 5 days postoperatively. The CD4+/CD8 + ratio, T lymphocyte subsets (including CD3 + T cells, CD4 + T cells, and CD8 + T cells), and natural killer (NK) cells were analyzed by flow cytometry. Serum interleukin-6 (IL-6), interferon -ɣ (IFN-ɣ), and vascular endothelial growth factor-α (VEGF-α) were also measured.

Results

The CD4+/CD8 + ratio decreased 24 h after surgery in two groups, but the reduction did not differ between the two groups (P > 0.05). The concentration of IL-6 and the numerical rating scale (NRS) score in the BIS 55 group were significantly higher than that in the BIS 35 group 24 h after surgery (P = 0.001). There were no intergroup differences in CD3 + T cells, CD4 + T cells, CD8 + T cells, NK cells, VEGF-α, or the IFN-ɣ. Statistical analyses showed no differences between the two groups in the incidence of fever and surgical site infection during hospitalization.

Conclusions

Despite the fact that patients in deep general anesthesia group had low levels of the IL-6 24 h after surgery, the deep general anesthesia was not associated to a positive effect on patients’ peripheral T lymphocytes during colorectal cancer surgery. We found no evidence that peripheral T lymphocyte subsets and natural killer cells were affected by the targeting a BIS of either 55 or 35 in patients undergoing laparoscopic colorectal cancer surgery in this trial.

Trial registration

ChiCTR2200056624 (www.chictr.org.cn).

Peer Review reports

Introduction

Worldwide, colorectal cancer (CRC) is the third most commonly diagnosed cancer, and the second for mortality [1, 2]. Surgical removal of CRC is the first-line treatment, postoperative recurrence and metastasis are of great significance for the prognosis of patients [3]. The perioperative period is considered to be a critical window for tumor spread and metastasis, as the impaired immunosurveillance, excessively increased growth factors, and the tumor cells released into circulation caused by surgical procedure [4, 5].

Immunosuppression is commonly observed in patients who underwent trauma and major surgery, which could be characterized by functional disturbances and quantity decline in lymphocytes [6, 7]. T lymphocytes, a major component of adaptive (acquired) immune systems, play important roles in cancer immunity [8]. Several factors can affect the perioperative immune status, and the surgical stress response is a critical factor for perioperative immunosuppression [9]. Therefore, the modulation of the perioperative stress response might be a therapeutic target to preserve the immunological function of patients. Previous studies suggest that anesthetics could counter the surgical stress response and reduce the release of inflammatory cytokines [10, 11]. The bispectral index (BIS) monitor is the most used instrument for instructing anesthetic delivery during operation, and the value of BIS is connected with the anesthetic concentrations and individual sensitivity [12]. However, few studies investigated the influence of BIS-guided anesthetic depth on immunological function.

Therefore, we tested the hypothesis that deep anesthesia (BIS 35) could control surgical stress response effectively, hence CD4+/CD8 + ratio in the deep general anesthesia group is higher than that in the light general anesthesia group (BIS 55). In addition, it was previously reported that high CD4+/CD8 + ratio correlated with stronger cellular immunity [13, 14]. This study aimed to compare the effect of deep anesthesia to light anesthesia on the changes in the CD4+/CD8 + ratio in patients with colorectal resection.

Methods and materials

Ethics and registration

Ethical approval

for this study (ethics: KY-20211130002-02) was provided by the Ethics Committee of the affiliated Lianyungang Hospital of Xuzhou Medical University, Lianyungang, China on 29 January 2022. The trial was registered in the Chinese Clinical Trial Registry (ChiCTR2200056624) on 09/02/2022 before enrollment. The study protocol followed the CONSORT guidelines. All participants signed written informed consent.

Patients inclusion and exclusion criteria

We studied patients aged between 18 and 75 years, with an American Society of Anesthesiologists (ASA) physical status of I or II and a BMI range from 18 kg m− 2 to 30 kg m− 2, who were undergoing elective laparoscopic colorectal cancer surgery under intravenous anesthetic-based general anesthesia without regional anesthesia, clearly understanding and voluntarily participating in the study, and signing the informed consent form. Patients were excluded for the following reasons: use of inhalation anesthesia, epidural anesthesia, or regional anesthesia; conversion from laparoscopic to open surgery; complicated with hematological and immunological diseases; a history of other malignant tumors, radiotherapy, chemotherapy, and blood transfusions within two weeks before the operation, and long-term use of immunosuppressive and anti-inflammatory medications.

Anesthesia

Patients were routinely monitored by an electrocardiogram (ECG), heart rate (HR), invasive arterial pressure (IBP), pulse oxygen saturation (SpO2), central venous pressure (CVP), and BIS once they entered the operating room. Before anesthesia induction, patients were blindly allocated to BIS 35 group or BIS 55 group according to a random number table. All patients were induced by 2.5-3 mg kg− 1 propofol, 0.3 ~ 0.4 µg kg− 1 sufentanil, and 0.15 mg kg− 1 cisatracurium in both two groups. After induction of anesthesia, propofol (4 ~ 12 mg kg− 1 h− 1) and remifentanil (3 ~ 18 µg kg− 1 h− 1) were pumped to maintain the anesthesia. Within 10 min of skin incision, the anesthetic depth must be adjusted to the target according to the allocation. It was not permitted to pursue BIS goals at the expense of patient safety.

The BIS ranges from 100 (awake) to 0 (flat line EEG), and as the number decreases, the anesthetic depth increases. During general anesthesia, a BIS value of 40 to 60 was recommended [15]. Based on previous research on anesthetic depth [16, 17] and manufacturer’s recommendations, we chose 35 and 55 as the deep general anesthesia and light general anesthesia group targets, respectively. In the BIS 35 group, patients’ BIS values should be kept between 30 and 40, and in the BIS 55 group, between 50 and 60. Cisatracurium was added in time as needed. A reasonable range (baseline mean atrial pressure ± 30%) of blood pressure fluctuation was established for each patient, and the mean arterial pressure was controlled within this range by pumping nitroglycerin and norepinephrine. At 7 different intraoperative time points (t0: preoperative, t1: immediately after induction, t2: immediately after incision, t3: immediately after pneumoperitoneum established, t4: 60 min after incision, t5: immediately after pneumoperitoneum disappeared, and t6: immediately after operation), we measured the MAP, HR, and BIS values for both groups. All drugs administered during the operation were recorded. Non-steroidal anti-inflammatory drugs (NSAIDs) or steroids was not used during the pre-, intra- and postoperative phase. All patients were provided with a patient-controlled intravenous analgesia (PCIA) pump. The PCIA protocol was sufentanil 2 µg kg− 1 in 100 ml saline. The parameters were as follows: background dose 2 ml hour− 1, PCA 2 ml each time with a locking time of 30 min.

Blood samples

Flow cytometry was used to determine the number of T lymphocyte subsets (including the CD4+/CD8 + ratio, CD3 + T cells, CD4 + T cells, and CD8 + T cells) and natural killer (NK) cells. Venous blood samples were collected immediately before anesthesia induction (T0), immediately after operation (T1), and at 24 h and 5 days postoperatively (T2 and T3). The concentrations of interleukin-6 (IL-6), interferon -ɣ (IFN-ɣ), and vascular endothelial growth factor-α (VEGF-α) were measured by commercial enzyme-linked immunosorbent assay kits (Cloud-clone ELISA kits; USA). A professional laboratory doctor tested the blood sample, and the results were uploaded to an electronic medical record system.

Clinical measurements

Before leaving the PACU (postanesthesia care unit), intraoperative awareness was evaluated using the Modified Brice Questionnaire. The level of postoperative pain at rest was assessed 1 day after surgery using a numeric rating scale (NRS) ranging from 0 (no pain) to 10 (most pain imaginable). Postoperative 24 h analgesic pump drug residual volume was obtained from the electronic analgesia pump system. Fever and incision site infections that occur during hospitalization are diagnosed by the surgeon in charge of the patient. Fever is defined as a postoperative temperature over 38 °C [18]. The diagnosis of surgical site infection was based upon patient’s combination of clinical and examination feature, laboratory and microbiologic data, and radiography results [19, 20].

Statistical analysis

On the principle of the intention-to-treat principle, all analyses were performed. All patients who were randomly assigned were included in the intention-to-treat group. The primary outcome was the CD4+/CD8 + ratio 24 h after surgery, while the secondary outcome measures were the number of lymphocyte subsets, intraoperative awareness, emergence time, NRS score, and analgesic pump drug residual volume at 24 h after surgery, as well as the incidences of surgical site infection and fever during hospitalization. According to the published data [21], the mean CD4+/CD8 + ratio at postoperative 24 h was estimated at 1.18 (with a standard deviation [SD] of approximately 0.56) and a difference of 0.5 was considered to be clinically significant. We calculated that 27 patients in each group would be required to detect this difference with a power of 0.90 at a significance level of 0.05 (two-sided). It was intended to enroll 60 patients, with a 10% drop-out rate.

Statistical analysis was performed using the SPSS software (Version 19.0; IBM Corporation, New York). The normality of data distribution was assessed by the Shapiro-Wilk test. Normally distributed continuous data were expressed as the mean ± standard deviation and analyzed using the t-test. The categorical variables were expressed as frequencies (percentages) and analyzed using the chi-square test. The Mann-Whitney U-test was used for continuous variables with a non-normal distribution. The differences in T lymphocyte subsets and NK cells over time were analyzed by Two-way analysis of variance (ANOVA) followed by Bonferroni correction. Statistical significance was set at P < 0.05.

Results

A total of 75 Patients were enrolled between February 15 and July 31, 2022. Figure 1 depicts the participant flow diagram. After 15 individuals were excluded, 60 patients were randomly divided into two groups and included in the analysis.

Fig. 1
figure 1

Flow diagram

Full size image

Baseline patient characteristics are shown in Table 1. The deep general anesthesia group (BIS 35) and light general anesthesia group (BIS 55) did not differ in age, height, weight, BMI, or sex. No differences were observed between the two groups in the grade of ASA, baseline mean arterial pressure (MAP) or heart rate (HR), operation type, or cancer stage.

Table 1 Baseline patient characteristics
Full size table

Intraoperative characteristics were shown in Table 2. Significant BIS disparity existed between the two groups. The average BIS for the BIS 35 group and the BIS 55 group, respectively, were 40.2 and 53.3 (P < 0.001). Figure 2 shows the changes in the MAP, HR and BIS at different time points in two groups. There were no intergroup differences in HR and MAP at 7 different time points. Compared with BIS 35 group, the value of BIS in the BIS 55 group was significantly higher at t3, t4, t5, and t6. There were no intergroup differences in duration of anesthesia or surgery, blood loss, infusion or urine volume, norepinephrine or nitroglycerin, or cisatracurium. The doses of total propofol and remifentanil were significantly higher in BIS 35 group (P = 0.018, P = 0.020 respectively).

Table 2 Intraoperative characteristics
Full size table
Fig. 2
figure 2

Changes in the MAP, HR and BIS over time in two groups (P = 0.501, P = 0.798 and P < 0.0001, respectively)

Full size image

Figure 3 shows the changes in CD4+/CD8 + ratio, CD3 + T cells and NK cells over time in two groups. The CD4+/CD8 + ratio decreased at T1 in two groups, but the reduction did not differ between the two groups (P > 0.05). The CD4+/CD8 + ratio did not differ significantly between the two groups over time (P = 0.910). The quantity of CD3 + T cells and NK cells decreased significantly at T1, T2, and T3 compared with T0, but the reduction did not differ between the two groups.

Fig. 3
figure 3

Changes in the CD4+/CD8 + ratio, CD3 + T cell and NK cell were not significantly different in the two groups (P = 0.910, P = 0.493 and P = 0.837, respectively)

Full size image

Figures 4 and 5 depict the changes in CD4 + T cells and CD8 + T cells, respectively. In compared to preoperative levels, the quantity of CD4 + T cells and CD8 + T cells significantly decreased at T1, T2, and T3. There were no significant intergroup differences.

Fig. 4
figure 4

Changes in CD4 + T cell was not significantly different in the two groups (P = 0.292)

Full size image
Fig. 5
figure 5

Changes in CD8 + T cell was not significantly different in the two groups (P = 0.837)

Full size image

Data on the serum cytokines are shown in Table 3. There were no significant differences in the concentrations of IFN-ɣ and VEGF-α between the two groups. At 24 h after operation, the concentration of IL-6 in the BIS 55 group was noticeably higher than that in the BIS 35 group (P = 0.001).

Table 3 Perioperative Cytokine Concentrations
Full size table

Postoperative characteristics is presented in Table 4. The NRS score of the BIS 35 group was significantly lower than the BIS 55 group after 24 h postoperatively (P = 0.001). In the two groups, there were no cases of perioperative awareness. There were no intergroup differences in emergence time, analgesic pump drug residual volume at 24 h after surgery, dose of total sufentanil, incidence of fever or surgical site infection during hospitalization.

Table 4 Postoperative characteristics
Full size table

Discussion

This trial assessed the effect of BIS-guided anesthetic depth on T lymphocytes. The results showed that deep general anesthesia (BIS 35) and light general anesthesia (BIS 55) had similar effects on the changes in CD4+/CD8 + ratio. They also had similar effects on the quantity of CD3 + T cells, CD4 + T cells, CD8 + T cells, and NK cells during laparoscopic colorectal cancer surgery.

The T Lymphocytes are affected by surgical manipulation and anesthetic during operation [22, 23]. The Surgical stress response caused by surgical manipulation is an important reason for the decline of perioperative immune function, which is a complex process of neuroendocrine-metabolic and inflammatory-immune response [9]. A crucial factor in immunosuppression is the inflammatory-immune response, and propofol is known to have an anti-inflammatory effect [24]. Remifentanil and sufentanil are the most commonly used opioids in surgery, with a strong analgesic effect. Furthermore, opioids have been shown to inhibit the hypothalamic-pituitary-adrenal (HPA) and sympathetic adrenal system (SAS) axis overactivation [4, 25, 26]. In their study, Wang et al. [27] discovered that BIS-guided deep anesthesia inhibits the perioperative stress response better than light anesthesia. Quan et al. [28] reported a positive correlation between increasing anesthetic depth and decreased inflammatory response. It was evident that anti-inflammatory treatments are beneficial to cancer patients [29]. Because it is unclear whether actively intervening to regulate anesthetic depth can protect the T lymphocytes and reduce other complications after surgery, therefore, we did the study to compare light general anesthesia and deep general anesthesia in patients undergoing laparoscopic colorectal cancer surgery.

The CD4+/CD8 + ratio is prognostic for cell immunity function and cancer patient outcome. High CD4+/CD8 + ratio has long been thought to be a key indicator of improved prognosis and higher cell immune function, however, there are some controversial opinions in the context of colorectal cancer [13, 14]. Few academics have the opposite opinion to that mentioned above [30]. The CD4+/CD8 + ratio decreased at T2 significantly compared with T0 in two groups, which was consistent to the results of previous study [21]. In this trial, we found that targeting a BIS of either 55 or 35 had similar effects on the changes in CD4+/CD8 + ratio.

Peripheral mature T lymphocytes are represented by CD3 + T lymphocytes, which subsequently develop into CD4 + T lymphocytes (CD3 + CD4+) and CD8 + T lymphocytes (CD3 + CD8+). By secreting a variety of cytokines and helping CD8 + cytotoxic T cells in dissolving and eliminating tumor cells, CD4 T cells predominantly mediate anti-tumor immunity [31]. Natural killer (NK) cells play an important role in suppressing cancer progression [32]. Surgical stress also inhibited the function of NK cells after colorectal surgery [33]. A previous study suggested that the level of interferon-ɣ in the supernatant indicates NK cell activity [34]. However, there was no significant difference in the levels of IFN-ɣ between the two groups, and deep anesthesia (BIS 35) had no effect on the decline in NK cell activity after laparoscopic colorectal surgery in our study.

It was obvious that patients in two groups showed a significant decline in all types of T lymphocyte cells and NK cells after surgery in this trial. Although the difference between two groups is not statistically significant, patients in the BIS 55 group appear to have higher T lymphocytes and NK cells than that in the BIS 35 group. Several in-vitro and animal studies reported that opioids might trigger immunosuppression and may result in an increase in cancer metastasis [35, 36]. In this trial, patients in the BIS 35 group received more remifentanil than the BIS 55 group, which may be related to the difference in the number of T lymphocytes and NK cells between the two groups. Opioids may theoretically preserve immune function by preventing overactivation of the HPA and SAS axis, but their direct immunosuppressive effects may be more pronounced in clinical background.

Consistent with the result of Quan et al. [28], the concentration of IL-6 in the BIS 55 group was markedly higher than that in the BIS 35 group 24 h after surgery. The NRS score was lower significantly in BIS 35 group, but the postoperative 24 h analgesic pump drug residual volume did not show significant differences between the two groups. The pro-inflammatory cytokine IL-6 is strongly associated with surgical stress response and its intensity [37]. Additionally, IL-6 level always be in line with the intensity of pain. Pain is also a trigger for immunosuppression [38]. Therefore, we considered that the difference in IL-6 level between the two groups caused by the anesthetic depth at 24 h after surgery is the cause of the inconsistency in NRS between groups. Higher IL-6 and NRS levels are both harmful to the immune system. However, the differences of IL-6 and NRS between two groups did not cause a significant intergroup difference in T lymphocytes in this trial. VEGF-α plays a major role in angiogenesis which was important for tumor growth, dissemination, and metastasis [39]. There was no significant difference in serum VEGF-α level between the two groups in this trial. However, these intergroup differences did not affect the T lymphocytes in patients after colorectal surgery.

Norepinephrine and nitroglycerin were used to regulate intraoperative blood pressure in this trial. Sympathetic nerves can influence immune system by activating adrenergic receptors, including negative regulation of T lymphocyte cells maturation and proliferation [40]. Exogenous norepinephrine may affect the number of peripheral T lymphocytes through this pathway. Nitric oxide (NO), a signaling molecule with numerous mechanisms and a multidirectional regulatory effect on the immune system, was released by nitroglycerin after enzymatic hydrolysis [41]. The current study reveals that NO has a facilitative influence on CD4 + T cell differentiation and CD8 + T cell activity [42]. However, the doses of norepinephrine and nitroglycerin were comparable between two groups.

Various factors, including hypothermia, fluid administration, and the patient’s preoperative immunological status, affect the perioperative immune system in addition to anesthetics and surgical stress [43,44,45]. In the context of a complicated interaction of these factors, the differences between the two groups caused by modulating the anesthetic depth on doses of anesthetics and stress response might be insufficient to affect the patients’ perioperative T lymphocytes.

There were several limitations in this trial. First, we did not achieve our target BIS values in both groups, which might have limited our ability to confirm a difference if one existed. Second, it might be weakly to detect the secondary outcomes due to the small sample size. Third, it was inevitable that the treatments in the ward might affect the results. Last but not least, we only assessed the peripheral T lymphocytes and NK cells in a short time which only partially reflects immune function. Future research is required to observe the patients’ long-term outcomes.

Conclusion.

According to our findings, patients who underwent laparoscopic colorectal cancer surgery experienced a prolonged period of lymphopenia. Although there was a tendency toward recovery at 5 days after surgery, it was still relatively low compared to preoperative levels. Despite the fact that patients in deep general anesthesia group had low levels of the pro-inflammatory factor IL-6 24 h after surgery, the deep general anesthesia was not associated to a positive effect on patients’ peripheral T lymphocytes during colorectal cancer surgery. We found no evidence that peripheral T lymphocyte subsets and natural killer cells were affected by the targeting a BIS of either 55 or 35 in patients undergoing laparoscopic colorectal cancer surgery in this trial.

Availability of data and materials

The datasets used and/or analyzed during the study are available from the corresponding author on reasonable request.

Abbreviations

BIS:

Bispectral index

IL-6:

Interleukin-6

IFN-ɣ:

Interferon-ɣ

VEGF-α:

Vascular endothelial growth factor-α

NK cell:

Natural killer cell

CRC:

Colorectal cancer

NRS:

Numerical rating scale

ECG:

Electrocardiogram

IBP:

Invasive arterial pressure

MAP:

Mean arterial pressure

CVP:

Central venous pressure

HR:

Heart rate

SpO2 :

Pulse oxygen saturation

ASA:

American Society of Anesthesiologists

PCIA:

Patient-controlled intravenous analgesia

PACU:

Postanesthesia care unit

NASIDs:

Non-steroidal anti-inflammatory drugs

ANOVA:

Analysis of variance

HPA:

Hypothalamic-pituitary-adrenal

SAS:

Sympathetic adrenal system

NO:

Nitric oxide

References

  1. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394–424.

    Article  PubMed  Google Scholar 

  2. Erratum. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2020;70:313.

    Article  Google Scholar 

  3. Engstrand J, Nilsson H, Strömberg C, Jonas E, Freedman J. Colorectal cancer liver metastases - a population-based study on incidence, management and survival. BMC Cancer. 2018;18:78.

    Article  PubMed  PubMed Central  Google Scholar 

  4. Cusack B, Buggy DJ. Anaesthesia, analgesia, and the surgical stress response. BJA Educ. 2020;20:321–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Gottschalk A, Sharma S, Ford J, Durieux ME, Tiouririne M. Review article: the role of the perioperative period in recurrence after cancer surgery. Anesth Analg. 2010;110:1636–43.

    Article  PubMed  Google Scholar 

  6. Marik PE, Flemmer M. The immune response to surgery and trauma: implications for treatment. J Trauma Acute Care Surg. 2012;73:801–8.

    Article  CAS  PubMed  Google Scholar 

  7. Lundy J, Ford CM. Surgery, trauma and immune suppression. Evolving the mechanism. Ann Surg. 1983;197:434–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Kishton RJ, Sukumar M, Restifo NP. Metabolic regulation of T cell longevity and function in Tumor Immunotherapy. Cell Metab. 2017;26:94–109.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Desborough JP. The stress response to trauma and surgery. Br J Anaesth. 2000;85:109–17.

    Article  CAS  PubMed  Google Scholar 

  10. Ouyang R, Ren H, Liu W, Yuan X, Lei E. Remifentanil inhibits the traumatic stress response in emergent trauma surgery. J Clin Lab Anal. 2019;33:e22971.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Sayed S, Idriss NK, Sayyedf HG, Ashry AA, Rafatt DM, Mohamed AO, et al. Effects of propofol and isoflurane on haemodynamics and the inflammatory response in cardiopulmonary bypass surgery. Br J Biomed Sci. 2015;72:93–101.

    Article  CAS  PubMed  Google Scholar 

  12. Punjasawadwong Y, Phongchiewboon A, Bunchungmongkol N. Bispectral index for improving anaesthetic delivery and postoperative recovery. Cochrane Database Syst Rev. 2014;2014:Cd003843.

    PubMed  PubMed Central  Google Scholar 

  13. Tímár J, Ladányi A, Forster-Horváth C, Lukits J, Döme B, Remenár E, et al. Neoadjuvant immunotherapy of oral squamous cell carcinoma modulates intratumoral CD4/CD8 ratio and tumor microenvironment: a multicenter phase II clinical trial. J Clin Oncol. 2005;23:3421–32.

    Article  PubMed  Google Scholar 

  14. Hori Y, Ibuki T, Hosokawa T, Tanaka Y. The effects of neurosurgical stress on peripheral lymphocyte subpopulations. J Clin Anesth. 2003;15:1–8.

    Article  PubMed  Google Scholar 

  15. Johansen JW, Sebel PS. Development and clinical application of electroencephalographic bispectrum monitoring. Anesthesiology. 2000;93:1336–44.

    Article  CAS  PubMed  Google Scholar 

  16. Short TG, Campbell D, Frampton C, Chan MTV, Myles PS, Corcoran TB, et al. Anaesthetic depth and complications after major surgery: an international, randomised controlled trial. Lancet. 2019;394:1907–14.

    Article  PubMed  Google Scholar 

  17. Kertai MD, Palanca BJ, Pal N, Burnside BA, Zhang L, Sadiq F, et al. Bispectral index monitoring, duration of bispectral index below 45, patient risk factors, and intermediate-term mortality after noncardiac surgery in the B-Unaware trial. Anesthesiology. 2011;114:545–56.

    Article  PubMed  Google Scholar 

  18. Stephenson C, Mohabbat A, Raslau D, Gilman E, Wight E, Kashiwagi D. Management of Common Postoperative Complications. Mayo Clin Proc. 2020;95:2540–2554.

  19. Seidelman J, Anderson DJ. Surgical Site Infections. Infect Dis Clin North Am. 2021;35:901–29.

    Article  PubMed  Google Scholar 

  20. Farah K, Lubiato A, Meyer M, Prost S, Ognard J, Blondel B, et al. Surgical site infection following surgery for spinal deformity: about 102 patients. Neurochirurgie. 2021;67:152–6.

    Article  CAS  PubMed  Google Scholar 

  21. Liu S, Gu X, Zhu L, Wu G, Zhou H, Song Y, et al. Effects of propofol and sevoflurane on perioperative immune response in patients undergoing laparoscopic radical hysterectomy for cervical cancer. Med (Baltim). 2016;95:e5479.

    Article  CAS  Google Scholar 

  22. Faisal M, Schäfer CN, Myrelid P, Winberg ME, Söderholm JD, Keita ÃV, et al. Effects of analgesic and surgical modality on immune response in colorectal cancer surgery. Surg Oncol. 2021;38:101602.

    Article  PubMed  Google Scholar 

  23. Nagasaka H, Ohno S, Kobayashi K, Sakagami H. [Effect of anesthetics on malignant tumor cells (a review)]. Masui. 2009;58:1216–25.

    PubMed  Google Scholar 

  24. Samir A, Gandreti N, Madhere M, Khan A, Brown M, Loomba V. Anti-inflammatory effects of propofol during cardiopulmonary bypass: a pilot study. Ann Card Anaesth. 2015;18:495–501.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Iwasaki M, Edmondson M, Sakamoto A, Ma D. Anesthesia, surgical stress, and “long-term” outcomes. Acta Anaesthesiol Taiwan. 2015;53:99–104.

    Article  PubMed  Google Scholar 

  26. Walker JJ, Terry JR, Lightman SL. Origin of ultradian pulsatility in the hypothalamic-pituitary-adrenal axis. Proc Biol Sci. 2010;277:1627–33.

    CAS  PubMed  PubMed Central  Google Scholar 

  27. Yang LQ, Li JJ, Chen SQ, Wang YW. Effect of different depths of anesthesia on perioperative stress response in children undergoing adenoidectomy and tonsillectomy. CNS Neurosci Ther. 2013;19:134–5.

    Article  CAS  PubMed  Google Scholar 

  28. Quan C, Chen J, Luo Y, Zhou L, He X, Liao Y, et al. BIS-guided deep anesthesia decreases short-term postoperative cognitive dysfunction and peripheral inflammation in elderly patients undergoing abdominal surgery. Brain Behav. 2019;9:e01238.

    Article  PubMed  PubMed Central  Google Scholar 

  29. Park JH, McMillan DC, Horgan PG, Roxburgh CS. The impact of anti-inflammatory agents on the outcome of patients with colorectal cancer. Cancer Treat Rev. 2014;40:68–77.

    Article  CAS  PubMed  Google Scholar 

  30. Diederichsen AC, Hjelmborg J, Christensen PB, Zeuthen J, Fenger C. Prognostic value of the CD4+/CD8 + ratio of tumour infiltrating lymphocytes in colorectal cancer and HLA-DR expression on tumour cells. Cancer Immunol Immunother. 2003;52:423–8.

    Article  CAS  PubMed  Google Scholar 

  31. Kamphorst AO, Ahmed R. CD4 T-cell immunotherapy for chronic viral infections and cancer. Immunotherapy. 2013;5:975–87.

    Article  CAS  PubMed  Google Scholar 

  32. Brittenden J, Heys SD, Ross J, Eremin O. Natural killer cells and cancer. Cancer. 1996;77:1226–43.

    Article  CAS  PubMed  Google Scholar 

  33. Angka L, Martel AB, Kilgour M, Jeong A, Sadiq M, de Souza CT, et al. Natural killer cell IFNγ secretion is profoundly suppressed following colorectal Cancer surgery. Ann Surg Oncol. 2018;25:3747–54.

    Article  PubMed  Google Scholar 

  34. Cho JS, Kim NY, Shim JK, Jun JH, Lee S, Kwak YL. The immunomodulatory effect of ketamine in colorectal cancer surgery: a randomized-controlled trial. Can J Anaesth. 2021;68:683–92.

    Article  CAS  PubMed  Google Scholar 

  35. Juneja R. Opioids and cancer recurrence. Curr Opin Support Palliat Care. 2014;8:91–101.

    Article  PubMed  Google Scholar 

  36. Fujioka N, Nguyen J, Chen C, Li Y, Pasrija T, Niehans G, et al. Morphine-induced epidermal growth factor pathway activation in non-small cell lung cancer. Anesth Analg. 2011;113:1353–64.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  37. Watt DG, Horgan PG, McMillan DC. Routine clinical markers of the magnitude of the systemic inflammatory response after elective operation: a systematic review. Surgery. 2015;157:362–80.

    Article  PubMed  Google Scholar 

  38. Amodeo G, Bugada D, Franchi S, Moschetti G, Grimaldi S, Panerai A, et al. Immune function after major surgical interventions: the effect of postoperative pain treatment. J Pain Res. 2018;11:1297–305.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  39. Canavese M, Ngo DT, Maddern GJ, Hardingham JE, Price TJ, Hauben E. Biology and therapeutic implications of VEGF-A splice isoforms and single-nucleotide polymorphisms in colorectal cancer. Int J Cancer. 2017;140:2183–91.

    Article  CAS  PubMed  Google Scholar 

  40. Grisanti LA, Perez DM, Porter JE. Modulation of immune cell function by α(1)-adrenergic receptor activation. Curr Top Membr. 2011;67:113–38.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  41. Hu Q, Shi J, Zhang J, Wang Y, Guo Y, Zhang Z. Progress and prospects of Regulatory Functions mediated by nitric oxide on immunity and immunotherapy. Adv Ther. 2021;4:2100032.

    Article  CAS  Google Scholar 

  42. Navasardyan I, Bonavida B. Regulation of T Cells in Cancer by Nitric Oxide. Cells. 2021;10.

  43. Jie HY, Ye JL, Zhou HH, Li YX. Perioperative restricted fluid therapy preserves immunological function in patients with colorectal cancer. World J Gastroenterol. 2014;20:15852–9.

    Article  PubMed  PubMed Central  Google Scholar 

  44. Appenheimer MM, Evans SS. Temperature and adaptive immunity. Handb Clin Neurol. 2018;156:397–415.

    Article  PubMed  Google Scholar 

  45. Cassinello F, Prieto I, del Olmo M, Rivas S, Strichartz GR. Cancer surgery: how may anesthesia influence outcome? J Clin Anesth. 2015;27:262–72.

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

Assistance with this study: staff of Emergency Laboratory and Gastrointestinal Surgery of The Affiliated Lianyungang Hospital of Xuzhou Medical University.

Funding

This research was supported by Lianyungang 521 project and Clinical Research Fund of The Affiliated Lianyungang Hospital of Xuzhou Medical University (LC13).

Author information

Authors and Affiliations

  1. Department of Anesthesiology, The Affiliated Lianyungang Hospital of Xuzhou Medical University, No. 6 Zhenhua East Road, Lianyungang, Lianyungang, 222000, China

    Han Li, Jiachi Li, Hengfei Luan, Xiaobao Zhang & Zhibin Zhao

  2. Jinzhou Medical University, No.40 Songpo Road, Jinzhou, Jinzhou, 121010, China

    Conghui Hao

Authors
  1. Han Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jiachi Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Conghui Hao
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Hengfei Luan
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Xiaobao Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Zhibin Zhao
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

Study design: Zhibin ZHAO, Hengfei LUAN, Xiaobao ZHANG. Patient recruitment: Han LI, Jiachi LI. Randomization and allocation: Han LI, Conghui HAO Data acquisition and analysis: Han LI, Jiachi LI, Conghui HAO. Drafting the manuscript: Han LI, Hengfei LUAN. Revision of the manuscript: all authors. All authors read and approved the final manuscript.

Corresponding author

Correspondence to Zhibin Zhao.

Ethics declarations

Competing interests

The authors declare that they have no affiliations with or involvement in any organization or entity with any financial interest in the subject matter or material discussed in this manuscript.

Ethics approval and consent to particiate

Ethical approval for this study (ethics: KY-20211130002-02) was provided by the Ethics Committee of the affiliated Lianyungang Hospital of Xuzhou Medical University, Lianyungang, China on 29 January 2022. Written informed consent was obtained from all participants. The trial was registered in the Chinese Clinical Trial Registry (ChiCTR2200056624) on 09/02/ 2022 before enrollment. All methods were performed in accordance with the Declaration of Helsinki.

Consent for publication

Not applicable.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Li, H., Li, J., Hao, C. et al. Effects of anesthetic depth on perioperative T lymphocyte subsets in patients undergoing laparoscopic colorectal cancer surgery: a prospective, parallel-controlled randomized trial. BMC Anesthesiol 23, 165 (2023). https://doi.org/10.1186/s12871-023-02129-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s12871-023-02129-6

Keywords

BMC Anesthesiology

ISSN: 1471-2253

Contact us